Stallergenes S.A.
Records under this name other than patents Stallergenes S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,555,102 | Compositions for antigen-specific induction of tolerance Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,610,586 | Compositions for antigen-specific induction of tolerance Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,632,993 | Method for grass species identification Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,795,644 | Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,375,690 | Pollen harvesting machine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,356,464 | Pollen harvesting machine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,272,162 | Method for preparing raw pollen Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,868,770 | Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposes Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,101,341 | Biomarkers of immunotherapy efficacy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,190,166 | Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy Formerly held In force · From the USPTO record | In force | From the USPTO record |